1-4 of 4
Hans-Guenter Derigs
Close
Sort by
Journal Articles

Azacitidine-Containing Induction Regimens Followed by Azacitidine Maintenance Therapy in High Risk Acute Myeloid Leukemia: First Results of the Randomized Phase-II AMLSG 12-09 Study (ClinicalTrials.gov No. NCT01180322)

Richard F Schlenk, MD, Wolfgang Herr, MD, Gerald Wulf, Helmut R Salih, MD, Jürgen Krauter, Prof. Dr. med., Hans Guenter Derigs, MD, Andrea Kündgen, Mark Ringhoffer, MD, Uwe M. Martens, MD, Bernd Hertenstein, Martin Griesshammer, MD, PhD, Michael Girschikofsky, MD, Helga Bernhard, MD, Jens Kersten, MD, Maria von Lilienfeld-Toal, MD, Elisabeth Koller, MD, Elisabeth Lange, MD, Jörg Westermann, MD, Daniela Späth, MSc, Gudrun Göhring, MD, Veronica Teleanu, MD, Axel Benner, Dipl.Stat., Konstanze Döhner, MD, Arnold Ganser, Hartmut Döhner, MD
Journal: Blood
Blood (2012) 120 (21): 412.
https://doi.org/10.1182/blood.V120.21.412.412
Published: 2012
Journal Articles

Combining Information Regarding Chromosomal Aberrations t(4;14), Del(17p13) and the Copy Number of 1q21 with the International Staging System Classification Allows Stratification of Myeloma Patients Undergoing Autologous Stem Cell Transplantation: Results From the HOVON-65/GMMG HD4 Trial

Kai Neben, MD, Henk M. Lokhorst, MD, Anna Jauch, PhD, Uta Bertsch, MD, Thomas Hielscher, Christiane Heiss, Bronno van der Holt, PhD, Stefan Schmitt, Laila el Jarari, MSc, Hans J. Salwender, MD, Igor W. Blau, Michael Pfreundschuh, MD, Katja Weisel, MD, Ulrich Duehrsen, MD, Walter Lindemann, Christian Teschendorf, Hans Martin, Christof Scheid, Mathias Haenel, MD, Hans Guenter Derigs, Ullrich Graeven, Ingo GH Schmidt-Wolf, Norma Peter, Mohammed Wattad, MD, Steffen P Luntz, Annemiek Broyl, MD, Joerg Schubert, MD, Martin Hoffmann, Martin Goerner, MD, Jochen Tischler, Martin Kaufmann, MD, Marc S Raab, Anthony D. Ho, MD, Helgi van de Velde, MD, PhD, Dirk Hose, MD, Pieter Sonneveld, MD, PhD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2011) 118 (21): 332.
https://doi.org/10.1182/blood.V118.21.332.332
Published: 2011
Journal Articles

Bortezomib-Based Induction Therapy Followed by Autologous Stem Cell Transplantation and Maintenance Therapy with Bortezomib Improves Outcome In Myeloma Patients with Gain 1q21 and t(4;14) - a Subgroup Analysis of the HOVON-65/GMMG-HD4 Trial

Hartmut Goldschmidt, Kai Neben, Uta Bertsch, Thomas Hielscher, Bronno van der Holt, Dirk Hose, Laila el Jarari, Hans Salwender, Igor Wolfgang Blau, Michael Pfreundschuh, Ulrich Duehrsen, Katja Weisel, Hans Martin, Walter Lindemann, Christian Teschendorf, Mathias Haenel, Christof Scheid, Helgi van de Velde, Hans Guenter Derigs, Martin Hoffmann, Norma Peter, Martin Kaufmann, Ingo Schmidt-Wolf, Anna Jauch, Henk M Lokhorst, Pieter Sonneveld
Journal: Blood
Blood (2010) 116 (21): 305.
https://doi.org/10.1182/blood.V116.21.305.305
Published: 2010
Journal Articles

Isocitrate Dehydrogenase Gene Mutations In Elderly Patients with Acute Myeloid Leukemia (AML) and Outcome After Treatment with All-Trans Retinoic Acid: A Study of the German-Austrian AML Study Group (AMSLG)

Peter Paschka, MD, Richard F. Schlenk, MD, Mariam Ibañez, Alexandra Kagias, Lars Bullinger, MD, Verena I. Gaidzik, MD, Daniela Späth, Heinz A. Horst, MD, PhD, Gerhard Held, MD, Martin Bentz, MD, Stephan Kremers, MD, Richard Greil, MD, Mohammed Wattad, MD, Wolfram Brugger, MD, PhD, Volker Runde, MD, Aruna Raghavachar, MD, Hans-Guenter Derigs, Heinrich Kirchen, MD, Hartmut Döhner, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2010) 116 (21): 101.
https://doi.org/10.1182/blood.V116.21.101.101
Published: 2010